Cabot Corporation (NYSE: CBT) saw its shares tumble 5.61% in after-hours trading on Monday following the release of its fourth-quarter earnings report and fiscal year 2026 guidance. The specialty chemicals and performance materials company faced headwinds in key segments, leading to a significant revenue miss and a cautious outlook.

For the fourth quarter, Cabot reported sales of $899 million, falling short of analyst expectations of $962.9 million. While the company's adjusted earnings per share of $1.70 met consensus estimates, the top-line miss highlighted challenges in its core businesses. The Reinforcement Materials segment experienced lower volumes, particularly in the Americas and Asia Pacific regions, while the Performance Chemicals segment grappled with weaker demand, especially in Europe.

Looking ahead, Cabot provided a tepid outlook for fiscal year 2026, projecting adjusted earnings per share in the range of $6.00 to $7.00. This guidance falls below the company's fiscal 2025 adjusted EPS of $7.25, signaling ongoing concerns about market conditions. CEO Sean Keohane cited a "challenging macroeconomic backdrop" and "competitive headwinds" as key factors influencing the company's conservative forecast.